Replies to post #265542 on NorthWest Biotherapeutics Inc (NWBO)

[ATLnsider]

I would add this spin as number 5:

5. "Even if the topline data is positive, and the trial results meets its primary & secondary endpoints, the stock price will only increase to $1 to $2 per share'.

[Looking4aprofit]

Yup, trotting out the ‘ole playbook and then play Table Tennis with “similarly” minded “investors” to lend some cred to the crud!

GLTALs